Mutita Junking
5PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 16, 2025
Enhanced cytotoxicity against cholangiocarcinoma by fifth-generation chimeric antigen receptor T cells targeting integrin αvβ6 and secreting anti-PD-L1 scFv.Nattaporn Phanthaphol, Chalermchai Somboonpatarakun, Kwanpirom Suwanchiwasiri
|Jan 13, 2025
Engineered T cells secreting αB7-H3-αCD3 bispecific engagers for enhanced anti-tumor activity against B7-H3 positive multiple myeloma: a novel therapeutic approach.Punchita Rujirachaivej, Teerapong Siriboonpiputtana, Kornkan Choomee
|Apr 29, 2024
Therapeutic potential of third-generation chimeric antigen receptor T cells targeting B cell maturation antigen for treating multiple myeloma.Punchita Rujirachaivej, Teerapong Siriboonpiputtana, Piriya Luangwattananun
|Sep 28, 2020
Anti-Proliferative Effects of Compound A and Its Effect in Combination with Cisplatin in Cholangiocarcinoma Cells.Mutita Junking, Thidarath Rattanaburee, Aussara Panya
|Jan 25, 2020
Suppression of TGF-β and IL-10 receptors on self-differentiated dendritic cells by short-hairpin RNAs enhanced activation of effector T-cells against cholangiocarcinoma cells.Chutamas Thepmalee, Aussara Panya, Jatuporn Sujjitjoon
Pageof 1
